EU industry pools energies in bid to shape safe sourcing regulations
This article was originally published in Clinica
Medical device companies operating in the EU have a number of "serious concerns" about two pieces of impending EU legislation that are intended to shape the future regulation of human tissue engineered products. The area is a complex, and moreover is one that could be hijacked by a misconceived ethical lobby. The task at hand is for industry therefore to proactively educate the decision-makers and opinion-formers, delegates heard at the recent Management Forum conference on Human Tissue Products, in London on November 19.